Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Gotuzzo E, Yactayo S, Córdova E.

Am J Trop Med Hyg. 2013 Sep;89(3):434-44. doi: 10.4269/ajtmh.13-0264. Review.

2.

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.

3.

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, Canderan G, Lawson B, Kopycinski J, Graham AS, Rowe DK, Smith MJ, Isern S, Michael S, Silvestri G, Vanderford TH, Castro E, Pantaleo G, Singer J, Gillmour J, Kiwanuka N, Nanvubya A, Schmidt C, Birungi J, Cox J, Haddad EK, Kaleebu P, Fast P, Sekaly RP, Trautmann L, Gaucher D.

J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9. Erratum in: J Clin Invest. 2014 Oct 1;124(10):4669. Gaucher, Denis [Added].

4.

Yellow fever vaccine: an effective vaccine for travelers.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2014;10(1):126-8. doi: 10.4161/hv.26549. Epub 2013 Sep 20.

5.

Yellow fever vaccine for patients with HIV infection.

Barte H, Horvath TH, Rutherford GW.

Cochrane Database Syst Rev. 2014 Jan 23;(1):CD010929. doi: 10.1002/14651858.CD010929.pub2. Review.

PMID:
24453061
6.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
7.

Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.

Bassi MR, Larsen MA, Kongsgaard M, Rasmussen M, Buus S, Stryhn A, Thomsen AR, Christensen JP.

PLoS Negl Trop Dis. 2016 Feb 17;10(2):e0004464. doi: 10.1371/journal.pntd.0004464. eCollection 2016 Feb.

8.

Duration of post-vaccination immunity against yellow fever in adults.

Collaborative group for studies on yellow fever vaccines..

Vaccine. 2014 Sep 3;32(39):4977-84. doi: 10.1016/j.vaccine.2014.07.021. Epub 2014 Jul 29.

9.

Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.

Alberer M, Burchard G, Jelinek T, Reisinger E, Beran J, Hlavata LC, Forleo-Neto E, Dagnew AF, Arora AK.

J Travel Med. 2015 Jan-Feb;22(1):48-56. doi: 10.1111/jtm.12164. Epub 2014 Oct 13.

10.

Yellow fever vaccination: is one dose always enough?

Patel D, Simons H.

Travel Med Infect Dis. 2013 Sep-Oct;11(5):266-73. doi: 10.1016/j.tmaid.2013.08.007. Epub 2013 Sep 5. Review.

PMID:
24074827
11.

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.

Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG.

PLoS One. 2008 Apr 23;3(4):e1993. doi: 10.1371/journal.pone.0001993.

12.

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.

Nasveld PE, Marjason J, Bennett S, Aaskov J, Elliott S, McCarthy K, Kanesa-Thasan N, Feroldi E, Reid M.

Hum Vaccin. 2010 Nov;6(11):906-14. doi: 10.4161/hv.6.11.12854. Epub 2010 Nov 1.

13.

Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.

Who..

Vaccine. 2015 Jan 1;33(1):76-7. doi: 10.1016/j.vaccine.2014.05.040. Epub 2014 May 20.

PMID:
24852721
14.

Booster dose after 10 years is recommended following 17DD-YF primary vaccination.

Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, Fonseca CT, Teixeira-Carvalho A, Villela-Rezende G, Santos RA, Batista MA, Campos FM, Pacheco-Porto L, Melo Júnior OA, Hossell DM, Coelho-dos-Reis JG, Peruhype-Magalhães V, Costa-Silva MF, de Oliveira JG, Farias RH, Noronha TG, Lemos JA, von Doellinger Vdos R, Simões M, de Souza MM, Malaquias LC, Persi HR, Pereira JM, Martins JA, Dornelas-Ribeiro M, Vinhas Ade A, Alves TR, Maia Mde L, Freire Mda S, Martins Rde M, Homma A, Romano AP, Domingues CM, Tauil PL, Vasconcelos PF, Rios M, Caldas IR, Camacho LA, Martins-Filho OA.

Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693.

15.

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

Michel R, Berger F, Ravelonarivo J, Dussart P, Dia M, Nacher M, Rogier S, Moua D, Sarr FD, Diop OM, Sall AA, Baril L.

Vaccine. 2015 May 11;33(20):2301-6. doi: 10.1016/j.vaccine.2015.03.069. Epub 2015 Apr 2.

PMID:
25843268
16.

Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses.

Neves PC, Santos JR, Tubarão LN, Bonaldo MC, Galler R.

PLoS One. 2013 Dec 6;8(12):e81953. doi: 10.1371/journal.pone.0081953. eCollection 2013.

17.

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.

Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D.

Curr HIV Res. 2010 Sep;8(6):461-6.

PMID:
20636276
18.

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Gibney KB, Edupuganti S, Panella AJ, Kosoy OI, Delorey MJ, Lanciotti RS, Mulligan MJ, Fischer M, Staples JE.

Am J Trop Med Hyg. 2012 Dec;87(6):1112-5. doi: 10.4269/ajtmh.2012.12-0182. Epub 2012 Oct 29.

19.

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Staples JE, Bocchini JA Jr, Rubin L, Fischer M; Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):647-50.

20.

Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali.

Sidibe M, Yactayo S, Kalle A, Sall AA, Sow S, Ndoutabe M, Perea W, Avokey F, Lewis RF, Veit O.

Trans R Soc Trop Med Hyg. 2012 Jul;106(7):437-44. doi: 10.1016/j.trstmh.2012.04.002. Epub 2012 May 22.

PMID:
22627101

Supplemental Content

Support Center